EVO301

Advertisement

cGxPJobs Banner

EVO301 Phase 2a Data Show Promise in Dermatitis

PALO ALTO, Calif. & NEW YORK, Feb. 10, 2026 — Clinical-stage biotechnology company Evommune announced positive top-line results from...

By cGxPwire Editor
February 10, 2026

Read More

Advertisement

cGxPJobs

Directory